{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:43:15Z","timestamp":1791726195164,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2025A1515010257"],"award-info":[{"award-number":["2025A1515010257"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Science and Technology Innovation Commission Outstanding Youth Basic Research Project","award":["RCYX20221008093032008"],"award-info":[{"award-number":["RCYX20221008093032008"]}]},{"name":"Shenzhen People's Hospital Clinical Scientist Cultivation Project","award":["SYWGSJCYJ202405"],"award-info":[{"award-number":["SYWGSJCYJ202405"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04348-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:22:39Z","timestamp":1773746559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma"],"prefix":"10.1007","volume":"75","author":[{"given":"Xueying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yepeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaowei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaishang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"4348_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.mayocp.2020.06.031","volume":"96","author":"J Chahoud","year":"2021","unstructured":"Chahoud J, Kohli M, Spiess PE (2021) Management of advanced penile cancer. Mayo Clin Proc 96:720\u2013732. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.031","journal-title":"Mayo Clin Proc"},{"key":"4348_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41585-021-00557-y","volume":"19","author":"M Bandini","year":"2022","unstructured":"Bandini M, Ahmed M, Basile G, Watkin N, Master V, Zhu Y, Prakash G, Rodriguez A, Ssebakumba MK, Leni R et al (2022) A global approach to improving penile cancer care. Nat Rev Urol 19:231\u2013239. https:\/\/doi.org\/10.1038\/s41585-021-00557-y","journal-title":"Nat Rev Urol"},{"key":"4348_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","volume":"83","author":"OR Brouwer","year":"2023","unstructured":"Brouwer OR, Albersen M, Parnham A, Protzel C, Pettaway CA, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J et al (2023) European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update. Eur Urol 83:548\u2013560. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.027","journal-title":"Eur Urol"},{"key":"4348_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41585-022-00617-x","volume":"19","author":"VB Joshi","year":"2022","unstructured":"Joshi VB, Spiess PE, Necchi A, Pettaway CA, Chahoud J (2022) Immune-based therapies in penile cancer. Nat Rev Urol 19:457\u2013474. https:\/\/doi.org\/10.1038\/s41585-022-00617-x","journal-title":"Nat Rev Urol"},{"key":"4348_CR5","doi-asserted-by":"publisher","first-page":"e00216","DOI":"10.1002\/advs.202500216","volume":"12","author":"H Song","year":"2025","unstructured":"Song H, Tong Z, Xie G, Li Y, Zhao Y, Fan F, Yang Z, Shi Q, Zhang Q, Wen F et al (2025) Single-cell and spatial transcriptomic profiling of penile squamous cell carcinoma reveals dynamics of tumor differentiation and immune microenvironment. Adv Sci 12:e00216. https:\/\/doi.org\/10.1002\/advs.202500216","journal-title":"Adv Sci"},{"key":"4348_CR6","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS (2022) Tertiary lymphoid structures in cancer. Science 375:eabf9419. https:\/\/doi.org\/10.1126\/science.abf9419","journal-title":"Science"},{"key":"4348_CR7","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","volume":"13","author":"N Horeweg","year":"2022","unstructured":"Horeweg N, Workel HH, Loiero D, Church DN, Vermij L, L\u00e9on-Castillo A, Krog RT, de Boer SM, Nout RA, Powell ME et al (2022) Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. Nat Commun 13:1373. https:\/\/doi.org\/10.1038\/s41467-022-29040-x","journal-title":"Nat Commun"},{"key":"4348_CR8","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1158\/2326-6066.Cir-20-0432","volume":"8","author":"AB Rodriguez","year":"2020","unstructured":"Rodriguez AB, Engelhard VH (2020) Insights into tumor-associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy. Cancer Immunol Res 8:1338\u20131345. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0432","journal-title":"Cancer Immunol Res"},{"key":"4348_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","volume":"9","author":"N Guti\u00e9rrez-Melo","year":"2023","unstructured":"Guti\u00e9rrez-Melo N, Baumjohann D (2023) T follicular helper cells in cancer. Trends Cancer 9:309\u2013325. https:\/\/doi.org\/10.1016\/j.trecan.2022.12.007","journal-title":"Trends Cancer"},{"key":"4348_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1158\/2326-6066.Cir-24-0299","volume":"13","author":"J Lehmann","year":"2025","unstructured":"Lehmann J, Thelen M, Kreer C, Schran S, Garcia-Marquez MA, Cisic I, Siepmann K, Hagen EM, Eckel HNC, Lohneis P et al (2025) Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs, but show increased T-cell activation. Cancer Immunol Res 13:323\u2013336. https:\/\/doi.org\/10.1158\/2326-6066.Cir-24-0299","journal-title":"Cancer Immunol Res"},{"key":"4348_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougo\u00fcin A, Pupier G, Calvez A, Giglioli I, Verkarre V, Lacroix G, Verneau J et al (2022) Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55:527-541.e525. https:\/\/doi.org\/10.1016\/j.immuni.2022.02.001","journal-title":"Immunity"},{"key":"4348_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005539","author":"M He","year":"2023","unstructured":"He M, He Q, Cai X, Liu J, Deng H, Li F, Zhong R, Lu Y, Peng H, Wu X et al (2023) Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-005539","journal-title":"J Immunother Cancer"},{"key":"4348_CR13","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Zhang MJ, Zhang B, Lin WP, Li SJ, Xiong D, Wang Q, Wang WD, Yang QC, Huang CF et al (2025) Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer. Nat Commun 16:4228. https:\/\/doi.org\/10.1038\/s41467-025-59341-w","journal-title":"Nat Commun"},{"key":"4348_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","volume":"76","author":"GY Ding","year":"2022","unstructured":"Ding GY, Ma JQ, Yun JP, Chen X, Ling Y, Zhang S, Shi JY, Chang YQ, Ji Y, Wang XY et al (2022) Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. J Hepatol 76:608\u2013618. https:\/\/doi.org\/10.1016\/j.jhep.2021.10.030","journal-title":"J Hepatol"},{"key":"4348_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009232","author":"YY Zhao","year":"2024","unstructured":"Zhao YY, Fan Z, Tao BR, Du ZG, Shi ZF (2024) Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-009232","journal-title":"J Immunother Cancer"},{"key":"4348_CR16","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"54","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, Burr AHP, Tometich JT, Bhattacharjee A, Bruno TC, Vignali DAA, Hand TW (2021) Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity 54:2812\u20132824. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.003","journal-title":"Immunity"},{"key":"4348_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke L, Brunet M, Gu\u00e9gan JP, Rey C, Bougouin A, Cousin S, Moulec SL, Besse B, Loriot Y, Larroquette M et al (2021) Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat Cancer 2:794\u2013802. https:\/\/doi.org\/10.1038\/s43018-021-00232-6","journal-title":"Nat Cancer"},{"key":"4348_CR18","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1172\/jci125044","volume":"129","author":"HO Reed","year":"2019","unstructured":"Reed HO, Wang L, Sonett J, Chen M, Yang J, Li L, Aradi P, Jakus Z, D\u2019Armiento J, Hancock WW, Kahn ML (2019) Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage. J Clin Invest 129:2514\u20132526. https:\/\/doi.org\/10.1172\/jci125044","journal-title":"J Clin Invest"},{"key":"4348_CR19","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.7150\/thno.113940","volume":"15","author":"GL Su","year":"2025","unstructured":"Su GL, Zhang MJ, Li H, Sun ZJ (2025) Dissecting tertiary lymphoid structures in cancer: maturation, localization and density. Theranostics 15:9459\u20139485. https:\/\/doi.org\/10.7150\/thno.113940","journal-title":"Theranostics"},{"key":"4348_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","volume":"17","author":"L Munoz-Erazo","year":"2020","unstructured":"Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA (2020) Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol Immunol 17:570\u2013575. https:\/\/doi.org\/10.1038\/s41423-020-0457-0","journal-title":"Cell Mol Immunol"},{"key":"4348_CR21","doi-asserted-by":"publisher","first-page":"e70062","DOI":"10.1111\/imr.70062","volume":"335","author":"NH Ruddle","year":"2025","unstructured":"Ruddle NH (2025) From lymphotoxin to tertiary lymphoid structures and beyond. Immunol Rev 335:e70062. https:\/\/doi.org\/10.1111\/imr.70062","journal-title":"Immunol Rev"},{"key":"4348_CR22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki M, Zebboudj A, Yano H, Zhang SL, Payne G, Chandra AK, Yu R, Guasp P, Sethna ZM, Ohmoto A et al (2025) IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature 638:1076\u20131084. https:\/\/doi.org\/10.1038\/s41586-024-08426-5","journal-title":"Nature"},{"key":"4348_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202509742","author":"T Xue","year":"2025","unstructured":"Xue T, Deng C, Liu J, Yan R, Li J, Hu X, Li X, Xiao X, Jin J, Tang H et al (2025) Spatial transcriptional dynamics of CD74+ B cells in tertiary lymphoid structures drive immune evolution in penile squamous cell carcinoma. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202509742","journal-title":"Adv Sci"},{"key":"4348_CR24","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.xcrm.2025.101934","volume":"6","author":"F Peyraud","year":"2025","unstructured":"Peyraud F, Gu\u00e9gan JP, Rey C, Lara O, Odin O, Del Castillo M, Vanhersecke L, Coindre JM, Clot E, Brunet M et al (2025) Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures. Cell Rep Med 6:101934. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101934","journal-title":"Cell Rep Med"},{"key":"4348_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","volume":"188","author":"L Onder","year":"2025","unstructured":"Onder L, Papadopoulou C, L\u00fctge A, Cheng HW, L\u00fctge M, Perez-Shibayama C, Gil-Cruz C, De Martin A, Kurz L, Cadosch N et al (2025) Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer. Cell 188:430-446.e420. https:\/\/doi.org\/10.1016\/j.cell.2024.10.042","journal-title":"Cell"},{"key":"4348_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41591-024-03324-9","volume":"31","author":"R Li","year":"2025","unstructured":"Li R, Villa NY, Yu X, Johnson JO, Borjas G, Dhillon J, Moran-Segura CM, Kim Y, Francis N, Dorman D et al (2025) Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial. Nat Med 31:176\u2013188. https:\/\/doi.org\/10.1038\/s41591-024-03324-9","journal-title":"Nat Med"},{"key":"4348_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","volume":"166","author":"C Hu","year":"2024","unstructured":"Hu C, You W, Kong D, Huang Y, Lu J, Zhao M, Jin Y, Peng R, Hua D, Kuang DM, Chen Y (2024) Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to Programmed Cell Death Protein 1 blockade in cancer immunotherapy. Gastroenterology 166:1069\u20131084. https:\/\/doi.org\/10.1053\/j.gastro.2023.10.022","journal-title":"Gastroenterology"},{"key":"4348_CR28","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","volume":"15","author":"L Kasikova","year":"2024","unstructured":"Kasikova L, Rakova J, Hensler M, Lanickova T, Tomankova J, Pasulka J, Drozenova J, Mojzisova K, Fialova A, Vosahlikova S et al (2024) Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nat Commun 15:2528. https:\/\/doi.org\/10.1038\/s41467-024-46873-w","journal-title":"Nat Commun"},{"key":"4348_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mdr2.70004","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R, Zhang P, Kadier K, Wang Y, Gu Q et al (2025) Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res Arch 1:10\u201331. https:\/\/doi.org\/10.1002\/mdr2.70004","journal-title":"Med Res Arch"},{"key":"4348_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.Ccr-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR (2023) Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res 29:1009\u20131016. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-1031","journal-title":"Clin Cancer Res"},{"key":"4348_CR31","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun C, Qin Z (2021) Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics 11:8322\u20138336. https:\/\/doi.org\/10.7150\/thno.62378","journal-title":"Theranostics"},{"key":"4348_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012069","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J, Zhou Z, Zhang L, Luo P, Zhang Z (2025) Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2025-012069","journal-title":"J Immunother Cancer"},{"key":"4348_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157215","author":"M Ukita","year":"2022","unstructured":"Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M et al (2022) CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.157215","journal-title":"JCI Insight"},{"key":"4348_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009603","author":"J Wang","year":"2024","unstructured":"Wang J, Liang Y, Xue A, Xiao J, Zhao X, Cao S, Li P, Dong J, Li Y, Xu Z, Yang L (2024) Intratumoral CXCL13(+) CD160(+) CD8(+) T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-009603","journal-title":"J Immunother Cancer"},{"key":"4348_CR35","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/all.14612","volume":"76","author":"ZZ Wang","year":"2021","unstructured":"Wang ZZ, Song J, Wang H, Li JX, Xiao Q, Yu Z, Wang ZC, Liu JX, Pan L, Yao Y et al (2021) Stromal cells and B cells orchestrate ectopic lymphoid tissue formation in nasal polyps. Allergy 76:1416\u20131431. https:\/\/doi.org\/10.1111\/all.14612","journal-title":"Allergy"},{"key":"4348_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/asn.2021040575","volume":"33","author":"O Ichii","year":"2022","unstructured":"Ichii O, Hosotani M, Masum MA, Horino T, Otani Y, Namba T, Nakamura T, Hosny Ali EY, Kon Y (2022) Close Association between Altered Urine-Urothelium Barrier and Tertiary Lymphoid Structure Formation in the Renal Pelvis during Nephritis. J Am Soc Nephrol 33:88\u2013107. https:\/\/doi.org\/10.1681\/asn.2021040575","journal-title":"J Am Soc Nephrol"},{"key":"4348_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810153","author":"EL Garcia-Villatoro","year":"2024","unstructured":"Garcia-Villatoro EL, Bomstein ZS, Allred KF, Callaway ES, Safe S, Chapkin RS, Jayaraman A, Allred CD (2024) Involvement of intestinal epithelium aryl hydrocarbon receptor expression and 3, 3\u02b9-diindolylmethane in colonic tertiary lymphoid tissue formation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251810153","journal-title":"Int J Mol Sci"},{"key":"4348_CR38","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, Wu W, Lei K, Zhang C, Tang M, Zhang Y, Xiang X, Tan L et al (2024) CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell 42:1370-1385.e1379. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006","journal-title":"Cancer Cell"},{"key":"4348_CR39","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez AB, Peske JD, Woods AN, Leick KM, Mauldin IS, Meneveau MO, Young SJ, Lindsay RS, Melssen MM, Cyranowski S et al (2021) Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep 36:109422. https:\/\/doi.org\/10.1016\/j.celrep.2021.109422","journal-title":"Cell Rep"},{"key":"4348_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mdr2.70040","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke X, Li K, Jiang A, Zhang Y, Wang Q, Li Z, Zhang J, Hajd A, Shi W, Kahlert U et al (2025) Cloud-based GWAS platform: an innovative solution for efficient acquisition and analysis of genomic data. Med Research 1:397\u2013411. https:\/\/doi.org\/10.1002\/mdr2.70040","journal-title":"Med Research"},{"key":"4348_CR41","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","volume":"186","author":"Y Chhabra","year":"2023","unstructured":"Chhabra Y, Weeraratna AT (2023) Fibroblasts in cancer: unity in heterogeneity. Cell 186:1580\u20131609. https:\/\/doi.org\/10.1016\/j.cell.2023.03.016","journal-title":"Cell"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04348-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04348-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04348-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:03:49Z","timestamp":1773792229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04348-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4348"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04348-5","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"109"}}